Professor, Department of Clinical Biochemistry and Pharmacology
Ben-Gurion University, Israel
Arik Dahan is an Assistant Professor of Pharmaceutics and Biopharmaceutics at the Department of Clinical Pharmacology and the School of Pharmacy, Ben-Gurion University of the Negev in Beer-Sheva, Israel. He is also an Adjunct Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Michigan. Dr. Dahan received his Ph.D. (2007) from the Hebrew University of Jerusalem. He was a Post-Doctoral Research Fellow at the University of Michigan (2007-2010) with Professor Gordon L. Amidon. Dr. Dahans research interest is the integration of up-to-date molecular/cellular mechanistic investigations of drug disposition in the context of the human body. In implementing this molecular biopharmaceutical approach to ADME research, Dr. Dahan is seeking to enable mechanistic-based successful solutions to drug delivery/therapy, in challenging scenarios e.g. low-solubility, low-permeability, extensive metabolism, poor site targeting, various pathophysiological conditions, and pediatrics. He has published over 50 top-notch Journal papers, and contributed chapters to 6 books.
BCS (Biopharmaceutics Classification System); Biopharmaceutics; Bioequivalence; Drug Solubility; Drug Targeting; Intestinal Permeability; Oral Drug Absorption; Pharmaceutical Sciences